Form 4: Phibro Animal Health CFO Settles Restricted Stock Units

Glenn David, CFO of Phibro Animal Health Corp, settles 30,000 Class A Common Stock restricted stock units.

Summary

• Glenn David, the Chief Financial Officer of Phibro Animal Health Corp, settled 30,000 Class A Common Stock restricted stock units (RSUs) on February 9, 2025.
• These shares were issued in settlement of RSUs, each representing a contingent right to receive one share of Class A Common Stock.
• No shares of Class A Common Stock were transferred or sold upon the vesting of the RSUs, and Mr. David will pay the related tax withholding obligations in cash.
• The reporting person now owns 30,000 Class A Common Stock.
• On February 9, 2024, Mr. David was granted 300,000 RSUs under the Issuer's 2008 Incentive Plan.
• 150,000 RSUs are subject to time vesting, vesting in equal installments over five years from the grant date.
• The other 150,000 RSUs are subject to performance vesting, based on the average closing stock price over a 90-day period ending five years from the grant date, with vesting dependent on the stock price ranging from $20 to $60 and above.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing an insider transaction. It doesn't inherently convey positive or negative sentiment.

Future Outlook

The document outlines the vesting schedule for the remaining RSUs, with both time-based and performance-based vesting conditions extending into the future.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the holdings and transactions of company executives. It is common practice for companies to grant stock-based compensation to align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock-based compensation, including RSUs, is a common practice among publicly traded companies to incentivize and retain key executives.
• The vesting schedules, both time-based and performance-based, are typical structures used to align executive compensation with long-term company performance.
• Companies like Zoetis, Elanco Animal Health, and Merck Animal Health also utilize similar compensation strategies for their executives.

Stakeholder Impact

• The settlement of RSUs has a minor dilutive effect on existing shareholders.
• The vesting schedule of the remaining RSUs incentivizes the CFO to focus on long-term company performance, which benefits shareholders.

Key Dates